Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 Jul;21(7):437.
doi: 10.1038/s41569-024-01044-8.

Aficamten reduces symptoms in obstructive hypertrophic cardiomyopathy

Gregory B Lim  1
Affiliations
Comment

Aficamten reduces symptoms in obstructive hypertrophic cardiomyopathy

Gregory B Lim. Nat Rev Cardiol. 2024 Jul.
No abstract available

PubMed Disclaimer

Comment on

  • Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
    Maron MS, Masri A, Nassif ME, Barriales-Villa R, Arad M, Cardim N, Choudhury L, Claggett B, Coats CJ, Düngen HD, Garcia-Pavia P, Hagège AA, Januzzi JL, Lee MMY, Lewis GD, Ma CS, Michels M, Olivotto I, Oreziak A, Owens AT, Spertus JA, Solomon SD, Tfelt-Hansen J, van Sinttruije M, Veselka J, Watkins H, Jacoby DL, Heitner SB, Kupfer S, Malik FI, Meng L, Wohltman A, Abraham TP; SEQUOIA-HCM Investigators. Maron MS, et al. N Engl J Med. 2024 May 30;390(20):1849-1861. doi: 10.1056/NEJMoa2401424. Epub 2024 May 13. N Engl J Med. 2024. PMID: 38739079 Clinical Trial.

References

Original article
    1. Maron, M. S. et al. Aficamten for symptomatic obstructive hypertrophic cardiomyopathy. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2401424 (2024)
Related article
    1. Lehman, S. J. et al. Targeting the sarcomere in inherited cardiomyopathies. Nat. Rev. Cardiol. 19, 353–363 (2022) - DOI - PubMed - PMC

MeSH terms

LinkOut - more resources